Framework Agreement for Pharmaceuticals with Accession Option
This framework agreement with an accession option covers various active ingredients and serves to inform pharmaceutical companies. It is not a public contract award.
CONTRACTING AUTHORITY
Name
BARMER Beschaffung und Vergabe
City
Wuppertal
Country
DE
CLASSIFICATION
Procedure Type
Open Procedure
Contract Type
Supplies
Main CPV
33600000 – Pharmaceutical products.
LOTS (42)
Addaven® + Generika (ATC B05XA31)
Cernevit® + Generika (ATC B05XC30)
Bexaroten
Buserelin (ohne Tierarzneimittel)
Candesartan + Amlodipin (8 mg/10 mg)
Caspofungin
Cefadroxil (ohne PSE)
Chinin
Dexamethason (AMP)
Dimethylfumarat (MS, 28 Stk. + N3, 190-200 Stk. + 120 mg, N2, 54-66 Stk.)
Eculizumab (Bekemv®/Epysqli®)
Eculizumab (Soliris®)
Eltrombopag (ausgenommen SAA)
Eltrombopag (Revolade®)
Enalapril (ohne Kinderarzneimittel)
Felbamat
Fesoterodin
Fluorouracil (dermal)
Fluticasonfuroat + Vilanterol
Follitropin delta
Ibuprofen (OTC, oral fest, ohne 24 Stk./PUL)
Ibuprofen (Rx, retardiert oral)
Imiglucerase
Latanoprost + Timolol (EDO)
Naproxen + Esomeprazol
Nilotinib (ausgenommen orale Verabreichung in Apfelmus)
Nilotinib (dispergierbar in Apfelmus)
Peginterferon beta-1a
Perindopril + Indapamid (10 mg/2,5 mg)
Pertuzumab + Trastuzumab (ILO, Fertigarzneimittel)
Poly(styrol-co-divinylbenzol)sulfonsäure, Natriumsalz (PUL)
Ponesimod
Rilpivirin (FTA)
Rivaroxaban (ohne GSE)
Sirolimus
Sulfasalazin (ausgenommen Rheuma)
Tafamidis
Tafluprost + Timolol
Teriparatid (Forsteo® + Generika)
Teriparatid (Livogiva®)
Teriparatid (Movymia®/Terrosa®)
Ticagrelor
ADDITIONAL DETAILS
Legal Basis
32014L0024
DEADLINES & TIMELINE
Submission Deadline
483 days remaining(LOT-0001)
Published